Table 1:

Characteristics and prevalence of cost-related nonadherence among respondents to the Canadian Community Health Survey in 2007

CharacteristicRespondents with complete data, no.Respondents who received a prescription, no.Respondents who reported cost- related nonadherence, no.Weighted prevalence of cost-related nonadherence,* % (95% CI)
Overall791757325409.6 (8.4–10.7)
Province
Atlantic provinces119188910511.9 (8.9–14.9)
Quebec15421062687.2 (4.5–9.8)
Ontario262919321689.1 (7.2–11.0)
Saskatchewan and Manitoba947686718.9 (6.0–11.7)
Alberta777565407.6 (4.6–10.7)
British Columbia8315988817.0 (12.6–21.4)
Age, yr
12–34211612951359.4 (7.2–11.6)
35–4412538098611.4 (8.2–14.7)
45–642813212122910.8 (8.7–12.9)
≥ 6517351507904.8 (3.6–6.0)
Sex
Female4363345335810.7 (9.2–12.2)
Male355422791828.2 (6.4–9.9)
Health status
Excellent or very good457329932076.9 (5.6–8.2)
Good2341182017310.4 (8.0–12.8)
Fair or poor100391916020.1 (15.7–24.4)
Chronic conditions, no.
0468727972218.2 (6.7–9.7)
11880163717111.2 (8.7–13.7)
≥ 21350129814812.4 (9.8–15.1)
Annual household income, $
< 20 00094876413620.5 (15.2–25.8)
20 000–39 9991663127014313.7 (10.7–16.7)
40 000–59 9991469105410210.5 (7.8–13.3)
60 000–79 99912368677110.4 (7.1–13.6)
≥ 80 00026011777885.4 (3.9–6.9)
Level of education
Less than high school178712281007.3 (4.9–9.8)
High school12138618111.9 (8.1–15.6)
Some postsecondary5163764812.8 (7.8–17.7)
Postsecondary graduate440132673119.2 (7.8–10.6)
Insurance coverage for prescription drugs
Yes650648403376.8 (5.7–7.8)
No141189220326.5 (21.8–31.3)
  • Note: CI = confidence interval.

  • * Percentages were calculated using number of respondents who reported receiving a prescription, weighted to represent the overall Canadian population.